SEC Form 4 · accession 0001127602-18-028314
Medtronic plc · MDT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Geoffrey Martha
Officer — EVP & GroupPres Restora Therap
Period of report
Sep 24, 2018
Accepted (ET)
Sep 25, 2018 · 4:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001613103
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Sep 24, 2018 | M | 28,670 | $34.88 | A | 87,872 | D | |
| Ordinary Shares | Sep 24, 2018 | M | 21,129 | $38.81 | A | 109,001 | D | |
| Ordinary SharesF1 | Sep 24, 2018 | S | 49,799 | $97.927 | D | 59,202 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $34.88 | Sep 24, 2018 | M | 28,670 | D | — | Aug 1, 2021 | Ordinary Shares | 28,670 | 0 | D |
| Stock Option (Right to Buy)F3 | $38.81 | Sep 24, 2018 | M | 21,129 | D | — | Jul 30, 2022 | Ordinary Shares | 21,129 | 0 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $97.911 to $97.965, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F2This option to purchase 28,670 ordinary shares of New Medtronic for $34.88 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 28,670 Medtronic common stock shares for $34.88 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
- F3This option to purchase 21,129 New Medtronic ordinary shares for $38.81 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 21,129 Medtronic common stock shares for $38.81 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.